Huffington Post Gay Voices Spotlights Asexuality

This morning the Huffington Post published the first article in a six-part feature on asexuality. It is being widely praised by the asexual community as an important and valuable tool in their ongoing work toward education and inclusion.

“It is very exciting to see a major news outlet like the Huffington Post cover asexuality so positively,” said Sara Beth Brooks, the founder of asexual organization Asexual Awareness Week. She continued, “Ms. Mosbergen really took the time to listen to our community and this series reflects that allyship. We look forward to more of her articles this week.” Each day this week, through Saturday June 22, a new part of the series will be posted.

No comments

Read more: Huffington Post Gay Voices Spotlights Asexuality

Boehringer Drops Out of HSDD Drug Race

One competitor dropped out of the race for the female Viagra. Many pharmaceutical companies want to capitalize on this market that could be worth a billion dollars. Boehringer International announced an end to its trials after its female viagra failed in early trials.

Girosa, like many of its competitors, did not target the post-menopausal women. Unlike Biosante's Libigel, Girosa did not attempt to correct the normal drop off in testosterone that occurs when women get older. Testosterone, which is normally considered to be the male sex hormone, controls the sex drive in both men and women.

The Food and Drug Administration recommended the company continue the trials on post-menopausal women, but the company decided to pull out. A spokesperson for the company said that they prefered to find out that the drug had failed early in the trials. Pharmaceutical companies spend much more money if they continue the research into later trials.

Asexuals are worried about the inclusion of Hyperactive Sexual Desire Disorder in the DSM. The DSM 5 splits the disorder into two conditions, one male and one female. Time Magazine and other sources have questioned the legitimacy of the decision to make a different diagnosis for women.

Boeheringer researchers originally intend the drug to work as an antidepressant. The drug failed its first test, but people taking the drug reported that it increased sex drive. Company marketers decided to enter the drug in the race for female Viagra.

Source:

A Drug Rejected

No comments

Campus Pride to Host Asexual Allyship Webinar

Campus Pride plans to hold an Asexual allyship webinar on April 23rd. Sara Beth Brooks, the founder of Asexual Awareness Week, will host the event. Brooks made the announcement during the first week of April.

No comments

Read more: Campus Pride to Host Asexual Allyship Webinar

French AVENites Declare Asexuality Day

The Asexual and Visibility Education Network in France celebrated Asexuality Day in April. Like many of AVEN's projects, the day is designed to raise awareness of the one percent of the population who does not experience sexual attraction, according to the Digital Journal.

French AVENites choose the day. Similar days occur in other countries, including the Asexual Visibility and Education Day, which takes place on October 12 in the United States, Canada, England, New Zealand, and Australia.  

Source: 

France Celebrates Asexuality Day

No comments

Livejournal User Starts New Aromantic Community

Aromantics have few online resources dedicated to them specifically. Very few forums existed for Aromantic people until recently. One Livejournal user decided to correct the issue, and create his own community.

No comments

Read more: Livejournal User Starts New Aromantic Community